PAPER Chen W, Johansen VB, Legido-Quigley C
SEARCH RESULTS
338953 RESULTS
PAPER Panizza E, Cerione RA
An interpretable deep learning framework identifies proteomic drivers of Alzheimer's disease.
Front Cell Dev Biol. 2024;12:1379984. Epub 2024 Sep 17 PubMed.PAPER Kametani F, Tahira M, Takao M, Matsubara T, Hasegawa K, Yoshida M, Saito Y, Murayama S, Hasegawa M
Analysis and comparison of post-translational modifications of α-synuclein filaments in multiple system atrophy and dementia with Lewy bodies.
Sci Rep. 2024 Oct 2;14(1):22892. PubMed.PAPER Conway T, Seidler K, Barrow M
Unlocking Choline's Potential in Alzheimer's Disease: A Narrative Review exploring the Neuroprotective and Neurotrophic role of Phosphatidylcholine and assessing its Impact on Memory and Learning.
Clin Nutr ESPEN. 2024 Sep 30; PubMed.PAPER Koirala S, Sharma H, Chew YL, Konopka A
SimplySmart_v1, a new tool for the analysis of DNA damage optimized in primary neuronal cultures.
BMC Bioinformatics. 2024 Oct 1;25(1):318. PubMed.PAPER Pan Y, Li L, Cao N, Liao J, Chen H, Zhang M
Advanced nano delivery system for stem cell therapy for Alzheimer's disease.
Biomaterials. 2024 Sep 30;314:122852. PubMed.PAPER Schwartz M, Colaiuta SP
Boosting peripheral immunity to fight neurodegeneration in the brain.
Trends Immunol. 2024 Oct 1; PubMed.PAPER Wlodarczyk J, Bhattacharyya R, Dore K, Ho GP, Martin DD, Mejias R, Hochrainer K
Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.
J Neurosci. 2024 Oct 2;44(40) PubMed.PAPER Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK
A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD).
Bioorg Med Chem. 2024 Sep 14;113:117925. PubMed.PAPER Dolgin E
Can flashing lights stall Alzheimer's? What the science shows.
Nature. 2024 Oct;634(8032):22-24. PubMed.PAPER Kavanagh T, Balcomb K, Ahmadi Rastegar D, Lourenco GF, Wisniewski T, Halliday G, Drummond E
hnRNP A1, hnRNP A2B1, and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology.
Brain Pathol. 2024 Oct 1;:e13305. PubMed.PAPER Xiong B, Song Z, Wang L, Zhang A, Zhou Y, Zheng N, Wei Y, Chen Y, Sun H
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?
ACS Chem Neurosci. 2024 Oct 2;15(19):3434-3436. Epub 2024 Sep 18 PubMed.PAPER Meng L, Jin H, Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Shoaie S, Turkez H, Nielsen J, Zhang C, Borén J, Uhlén M, Mardinoglu A
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease.
Alzheimers Res Ther. 2024 Oct 2;16(1):213. PubMed.PAPER Huang X, Wang Y, Xiang Y, Zhao Y, Pan H, Liu Z, Xu Q, Sun Q, Tan J, Yan X, Li J, Tang B, Guo J
Genetic Analysis of Neurite Outgrowth Inhibitor-Associated Genes in Parkinson's Disease: A Cross-Sectional Cohort Study.
CNS Neurosci Ther. 2024 Oct;30(10):e70070. PubMed.PAPER Yang Y, Wang Y, Jiang X, Mi J, Ge D, Tong Y, Zhu Y
Modified Ce/Zr-MOF Nanoparticles Loaded with Curcumin for Alzheimer's Disease via Multifunctional Modulation.
Int J Nanomedicine. 2024;19:9943-9959. Epub 2024 Sep 26 PubMed.Current Filters
No filters selected